Format

Send to

Choose Destination

See 1 citation in Diabetes Educ 2010:

Diabetes Educ. 2010 Sep-Oct;36(5):774-83. doi: 10.1177/0145721710374653. Epub 2010 Jun 28.

Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Author information

1
The Department of Medicine, Rhode Island Hospital, Providence, Rhode Island (Ms Grogan, Dr Abbott)
2
The Department of Medicine, Emory University School of Medicine, Atlanta, Georgia (Ms Jenkins)
3
The Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania (Ms Sansing, Ms MacGregor, Dr Brooks)
4
Georgetown University Medical Center, Washington, DC (Ms Julien-Williams)
5
New York University School of Medicine, New York, New York (Ms Amendola)

Abstract

PURPOSE:

The purpose of this study was to examine measures of chronic disease severity and treatment according to insurance status in a clinical trial setting.

METHODS:

Baseline insurance status of 776 patients with type 2 diabetes and stable coronary artery disease (CAD) enrolled in the United States in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial was analyzed with regard to measures of metabolic and cardiovascular risk factor control.

RESULTS:

Compared with patients with private or public insurance, the uninsured were younger, more often female, and less often white non-Hispanic. Uninsured patients had the greatest burden of CAD. Patients with public insurance were treated with the greatest number of medications, had the greatest self-reported functional status, and the lowest mean glycosylated hemoglobin and low-density lipoprotein (LDL) cholesterol values. Overall, for 5 measured risk factor targets, the mean number above goal was 2.49 ± 1.18. After adjustment for demographic and clinical variables, insurance status was not associated with a difference in risk factor control.

CONCLUSIONS:

In the BARI 2D trial, we did not observe a difference in baseline cardiovascular risk factor control according to insurance status. An important observation, however, was that risk factor control overall was suboptimal, which highlights the difficulty in treating type 2 diabetes and CAD irrespective of insurance status.

PMID:
20584997
DOI:
10.1177/0145721710374653
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center